ArticleJSES reviews, reports, and techniques2024
Use of pre-operative 3D planning software for revision shoulder arthroplasty: clinical experience data from a survey in a real-world setting.
Article in JSES reviews, reports, and techniques, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Restoring glenoid bone stock in failed anatomic shoulder arthroplasty: a cement-impression technique using femoral head allograft.JSES reviews, reports, and techniques · 2026Article
- Validation of a 3D planning tool for glenoid bone loss evaluation in revision anatomic total shoulder arthroplasty.BMC musculoskeletal disorders · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Preoperative 3D planning is routinely used in primary shoulder arthroplasty, while specific challenges in the revision setting make such approaches more cumbersome and less accessible. Recently, an established preoperative planning software (Blueprint; Stryker, Tornier SAS, Montbonnot-Saint-Martin, France) was expanded to offer a capability for planning of revision and complex primary shoulder arthroplasty cases. The aim of this study was to survey experienced surgeons on their perception of the new software feature for preoperative 3D planning in the setting of revision shoulder arthroplasty. Methods: An observational survey was conducted from January 2022 to October 2022 among orthopedic surgeons performing revision shoulder arthroplasty cases. The survey was part of the Early Product Surveillance program, with the primary goal of obtaining observational data from surgical experience in a real-world setting. A two-staged survey process was applied with separate questionnaires to seek voluntary feedback on the preoperative planning phase as well as on the intraoperative evaluation of the software planning features in revision shoulder arthroplasty. Results: Twenty-five fellowship-trained orthopedic surgeons from the USA and Canada participated in the survey and reported their feedback on 34 revision shoulder arthroplasty cases that were preoperatively planned with the use of Blueprint revision planning software. The surgeons were largely in favor of the revision software planning features and confirmed perceived benefits of its use in the preoperative planning stage of revision shoulder arthroplasty cases. Reported benefits in the preoperative planning phase included increased efficiency and improved ease of creating an appropriate surgical plan as well as increased confidence to execute revision shoulder arthroplasty cases. Surgeons also noted improvements in translation of preoperative planning to intraoperative execution of revision cases, including more appropriate implant selection and improved accuracy of implant placement. Conclusion: The feedback from fellowship-trained shoulder arthroplasty surgeons on the use of the new software feature for preoperative 3D planning of revision shoulder arthroplasty is largely favorable. Further research should be conducted to investigate whether these surgeon-perceived benefits can lead to improved clinical outcomes for patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.